Kirsch, B.; DuBois, J.; Chadha, D. A Multi-Center, Open-Label Study to Assess Pharmacokinetics (PK), Safety and Tolerability of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, ≥9 to ≪17 Years of Age, With Axillary Hyperhidrosis. J of Skin 2019, 3, S54.